Women in the latter study also had a lower median FAI and higher sex hormone binding globulin (SHBG) levels for both controls and PCOS, indicating a less severe endocrine presentation compared with those in the O'Reilly study. This evidence concerns the gene SHBG and polycystic ovary syndrome.